NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial

NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo‐controlled randomized trial

Abstract Objective To investigate the efficacy and safety of MLC901 in vascular cognitive impairment no dementia (VCIND) patients. Design This was a multi‐center, double‐blind, randomized, placebo‐controlled pilot study. Setting and participant VCIND patients from hospitals in Singapore (67), Vietna...

Full description

Bibliographic Details
Main Authors: Christopher L. H. Chen, Trọng Hung Nguyen, Simeon Marasigan, Chun Fan Lee, Qingshu Lu, Nagaendran Kandiah, Deidre deSilva, Eddie Chong, Narayanaswamy Venketasubramanian
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
clinical trial
executive function
MLC901
NEUROAID II
vascular cognitive impairment
Online Access:https://doi.org/10.1002/trc2.12161

Similar Items

Similar Items